Tailored therapy using dobutamine and nitroglycerin in advanced heart failure

被引：6
|
作者：
Drazner, MH
Solomon, MA
Thompson, B
Yancy, CW
机构：
[1] Univ Texas, SW Med Ctr, Div Cardiol, Dallas, TX 75235 USA
[2] St Paul Med Ctr, Dallas, TX USA
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 1999年 / 84卷 / 08期
关键词：
D O I：
10.1016/S0002-9149(99)00474-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In 29 patients with advanced heart failure, therapy tailored to hemodynamic goals was attempted using an initial infusion of dobutamine and nitroglycerin (the latter in those with pulmonary hypertension) followed by escalating doses of oral vasodilators. In the 23 patients who were weaned from inodilator therapy, significant improvements in hemodynamic parameters and a low 90-day hospital readmission rate were documented.
引用
收藏
页码：941 / +
页数：4
相关论文
共 50 条
  • [21] Rehospitalization of Patients with Advanced Heart Failure Receiving Continuous, Palliative Dobutamine or Milrinone
    Eaton, Rachael E.
    Kissling, Kevin T.
    Haas, Garrie J.
    McLaughlin, Eric M.
    Pickworth, Kerry K.
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 184 : 80 - 89
  • [22] Amiodarone Attenuates the Proarrhythmic Effects of Dobutamine in Patients with Advanced Congestive Heart Failure
    Tsagalou, Eleftheria P.
    Gounopoulos, Pantelis
    Terrovitis, John V.
    Drakos, Stavros G.
    Katsaros, Fotios T.
    Kaldara, Elisabeth E.
    Alexopoulos, George P.
    Anastasiou-Nana, Maria I.
    HELLENIC JOURNAL OF CARDIOLOGY, 2009, 50 (03) : 193 - 198
  • [23] Palliative Inotropes in Advanced Heart Failure: Comparing Outcomes Between Milrinone and Dobutamine
    Sami, Farhad
    Acharya, Prakash
    Noonan, Grace
    Maurides, Steven
    Al-Masry, Anas Abudan
    Bajwa, Suhaib
    Parimi, Nikhil
    Boda, Ilham
    Tran, Christina
    Goyal, Amandeep
    Mastoris, Ioannis
    Dalia, Tarun
    Sauer, Andrew
    Van Bakel, Adrian
    Shah, Zubair
    JOURNAL OF CARDIAC FAILURE, 2022, 28 (12) : 1683 - 1691
  • [24] Hemodynamic effects of levosimendan in addition to dobutamine infusion in patients with advanced heart failure intractable to dobutamine infusion alone
    Papazoglou, P
    Anastasiou-Nana, M
    Tsagalou, E
    Terrovitis, J
    Tsolakis, E
    Dalianis, A
    Alexopoulos, G
    Kanakakis, J
    Christodoulou, K
    Nanas, JN
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 206A - 206A
  • [25] Hemodynamically tailored therapy in congestive heart failure: Alive and well
    Nagueh, Sherif F.
    JOURNAL OF CARDIAC FAILURE, 2007, 13 (08) : 626 - 628
  • [26] Combined Therapy With Dobutamine and Omecamtiv Mecarbil in Pigs With Ischemic Acute Heart Failure Is Attributed to the Effect of Dobutamine
    Rodland, Lars
    Ronning, Leif
    Kildal, Anders Benjamin
    Myrmel, Truls
    How, Ole-Jakob
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2020, 25 (03) : 232 - 239
  • [27] Nesiritide Therapy Is Associated With Better Clinical Outcomes Than Dobutamine Therapy in Heart Failure
    Kong, Ling-Ge
    Wang, Chun-Li
    Zhao, Dan
    Wang, Bo
    AMERICAN JOURNAL OF THERAPEUTICS, 2017, 24 (02) : E181 - E188
  • [28] Direction of the Mitral Regurgitation (MR) Jet Does Not Influence Response to Tailored Therapy in Advanced Decompensated Heart Failure
    Dupont, Matthias
    Borowski, Allen G.
    Thomas, James D.
    Tang, W. H. Wilson
    JOURNAL OF CARDIAC FAILURE, 2012, 18 (08) : S10 - S10
  • [29] Advanced Heart Failure Due to Cancer Therapy
    Shah, Sachin
    Nohria, Anju
    CURRENT CARDIOLOGY REPORTS, 2015, 17 (04)
  • [30] Advanced Heart Failure Due to Cancer Therapy
    Sachin Shah
    Anju Nohria
    Current Cardiology Reports, 2015, 17
12345